Markus von Deimling
@mvdeimling
Followers
138
Following
180
Media
0
Statuses
64
MD, resident in urology @UKEHamburg | former research fellow @Uro_MedUniWien @MedUni_Wien | views are on my own
Hamburg, Vienna
Joined February 2022
RT @IMORU: Great talk by @TamsinGreenwel1 on a rare but important topic — female urethral reconstruction. World-class experts sharing their….
0
4
0
RT @Jon_Barclay: @JillC_Buckley sharing her roadmap for decision making around radiation-associated urethral stricture management - Very Us….
0
3
0
RT @IMORU: Welcoming the reconstructive urology community to Hamburg! Prof. Margit Fisch kicks off IMORU IX @UKEHamburg with live and semi-….
0
5
0
RT @mwvetterlein: Looking forward to an intensive 3-day reconstructive urology deep-dive in Hamburg, March 26-28. Registration is still ope….
0
3
0
RT @IMORU: The @IMORU 2025 program is set! Join us at @UKEHamburg for 20 live & 14 semi-live surgeries, expert lectures & interactive disc….
0
10
0
RT @NEJM: In patients with muscle-invasive bladder cancer, extended lymphadenectomy did not improve disease-free or overall survival as com….
0
112
0
RT @urotoday: Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive #BladderCancer. #BeyondT….
0
4
0
RT @urotoday: Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive #BladderCancer. #BeyondT….
0
1
0
RT @BJUIjournal: First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapy.@g….
0
12
0
RT @BJUIjournal: In cN+ #BladderCancer treated with cisplatin-based induction CTX followed by RC we found no difference in #PathologicalRes….
bjui-journals.onlinelibrary.wiley.com
Objective To investigate the optimal number of induction chemotherapy cycles needed to achieve a pathological response in patients with clinically lymph node-positive (cN+) bladder cancer (BCa) who...
0
8
0
We need procedure-specific comorbidity assessments, as standard comorbidity indices are too generic to predict postop. morbidity! Check out our latest paper @mwvetterlein @DrShariat @MichaelRink_MD @JakobFelin @M_Koelker @VMS78880496 @FredKoenig @PAEGild.
2
8
13
Check out our paper @BJUIjournal:.-> no oncologic benefit to extended PLND at RC in cN+ BCa regardless of periop chemo.~ 30% distant Mx.~ 13% locoregional rec.⛔️ cN+ is associated with a significant staging bias.Thanks to @BenjaminPradere and @DrShariat .
bjui-journals.onlinelibrary.wiley.com
Objective To determine the oncological impact of extended pelvic lymph node dissection (ePLND) vs standard PLND (sPLND) during radical cystectomy (RC) in clinically lymph node-positive (cN+) bladde...
1
11
27
RT @BJUIjournal: Online Now: Impact of the Extent of Lymph Node Dissection on Survival Outcomes in Clinically Lymph Node-Positive #BladderC….
bjui-journals.onlinelibrary.wiley.com
Objective To determine the oncological impact of extended pelvic lymph node dissection (ePLND) vs standard PLND (sPLND) during radical cystectomy (RC) in clinically lymph node-positive (cN+) bladde...
0
9
0
RT @urotoday: Carboplatin vs cisplatin-based chemotherapy for lymph node-positive #BladderCancer. #ExpertCommentary @FaltasLab @WCMEnglande….
0
7
0
RT @urotoday: Carboplatin vs cisplatin-based chemotherapy for lymph node-positive #BladderCancer. #ExpertCommentary @FaltasLab @WCMEnglande….
0
1
0
RT @urotoday: Neutrophil-to-lymphocyte ratio as a potential biomarker in patients with localized #UrothelialCarcinoma treated with chemothe….
0
1
0
RT @dr_rajwa: Novel systemic therapies are effective in men with mHSPC and mCRPC irrespective of visceral metastasis status . https://t.co/….
auajournals.org
Purpose:There are limited pooled data showing the impact of visceral metastasis on oncologic outcomes in metastatic prostate cancer patients treated with combination systemic therapies. We aimed to...
0
3
0
RT @urotoday: Carboplatin vs cisplatin-based chemotherapy for lymph node-positive #BladderCancer. #ExpertCommentary @FaltasLab @WCMEnglande….
0
4
0
RT @urotoday: Neutrophil-to-lymphocyte ratio as a potential biomarker in patients with localized #UrothelialCarcinoma treated with chemothe….
0
1
0